ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split
29 août 2024 16h50 HE
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Aug. 29, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ: ABIO) (“ARCA”) today announced completion of the merger with Oruka Therapeutics, Inc. (“Oruka”) following ARCA’s...
ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics
26 août 2024 19h30 HE
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Aug. 26, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ: ABIO) (“ARCA”) today announced an update to the previously announced final amount of the special cash dividend...
ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics
23 août 2024 16h30 HE
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Aug. 23, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ: ABIO) (“ARCA”) today announced that its Board of Directors (the “Board”) has approved a reverse stock split of...
ARCA biopharma Declares Special Dividend in Connection with the Proposed Merger with Oruka Therapeutics
16 août 2024 16h15 HE
|
ARCA biopharma, Inc.
Special dividend estimated to be $1.59 per share Payment of special dividend conditioned upon ARCA stockholder approval of the Proposed Merger with Oruka WESTMINSTER, Colo., Aug. 16, 2024 (GLOBE...
ARCA biopharma Announces Second Quarter 2024 Financial Results and Provides Corporate Update
01 août 2024 16h15 HE
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Aug. 01, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), (the “Company”) a biopharmaceutical company applying a precision medicine approach to developing...
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
25 avr. 2024 16h15 HE
|
ARCA biopharma, Inc.
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
03 avr. 2024 07h30 HE
|
ARCA biopharma, Inc.
Merger to create a company focused on advancing Oruka’s portfolio of novel biologics that aim to redefine the standard of care for patients with chronic skin diseases Oruka, the third company...
ARCA biopharma Announces 2023 Financial Results
01 févr. 2024 16h35 HE
|
ARCA biopharma, Inc.
ARCA biopharma Announces 2023 Financial Results
ARCA biopharma Announces Third Quarter 2023 Financial Results
18 oct. 2023 16h25 HE
|
ARCA biopharma, Inc.
ARCA biopharma Announces Third Quarter 2023 Financial Results
ARCA biopharma Announces Second Quarter 2023 Financial Results
21 juil. 2023 16h25 HE
|
ARCA biopharma, Inc.
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., July 21, 2023 (GLOBE...